Osteocalcin: Beyond Bones

Area of Science:

• Endocrinology
• Bone Biology
• Metabolic Health

Background:

• The skeletal system, beyond structural support, secretes hormones impacting whole-body homeostasis.
• Key bone-derived proteins include fibroblast growth factor 23, sclerostin, lipocalin 2, and osteocalcin.
• Osteocalcin, abundant in bone, is a marker for bone metabolism disorders and undergoes critical decarboxylation.

Purpose of the Study:

• To elucidate the hormonal functions of bone-derived proteins, particularly osteocalcin.
• To detail the process and significance of osteocalcin decarboxylation.
• To explore the metabolic and systemic effects of decarboxylated osteocalcin.

Main Methods:

• Analysis of osteocalcin transformations, focusing on decarboxylation.
• Investigating the release of decarboxylated osteocalcin into the bloodstream.
• Correlating decarboxylated osteocalcin levels with various metabolic parameters.

Main Results:

• Decarboxylation, occurring in acidic resorption environments, releases active osteocalcin.
• Decarboxylated osteocalcin enhances insulin secretion and pancreatic beta-cell proliferation.
• It reduces visceral fat accumulation, liver fat storage, and correlates inversely with BMI, body fat, and fasting glucose.

Conclusions:

• Osteocalcin exerts significant hormonal effects on metabolism, including glucose regulation and fat management.
• Decarboxylated osteocalcin influences testosterone production and glucagon-like peptide-1 synthesis.
• Osteocalcin is implicated in muscle-bone interactions and cognitive function, underscoring its systemic importance.